About the Authors
- Penny L. Moore
-
Affiliations AIDS Virus Research Unit, National Institute for Communicable Diseases, Johannesburg, South Africa, University of the Witwatersrand, Johannesburg, South Africa
- Nthabeleng Ranchobe
-
Affiliation AIDS Virus Research Unit, National Institute for Communicable Diseases, Johannesburg, South Africa
- Bronwen E. Lambson
-
Affiliation AIDS Virus Research Unit, National Institute for Communicable Diseases, Johannesburg, South Africa
- Elin S. Gray
-
Affiliation AIDS Virus Research Unit, National Institute for Communicable Diseases, Johannesburg, South Africa
- Eleanor Cave
-
Affiliation AIDS Virus Research Unit, National Institute for Communicable Diseases, Johannesburg, South Africa
- Melissa-Rose Abrahams
-
Affiliation Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa
- Gama Bandawe
-
Affiliation Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa
- Koleka Mlisana
-
Affiliation Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu Natal, Durban, South Africa
- Salim S. Abdool Karim
-
Affiliation Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu Natal, Durban, South Africa
- Carolyn Williamson
-
Affiliation Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa
- Lynn Morris
-
* E-mail: lynnm@nicd.ac.za
Affiliations AIDS Virus Research Unit, National Institute for Communicable Diseases, Johannesburg, South Africa, University of the Witwatersrand, Johannesburg, South Africa
- the CAPRISA 002 study and the NIAID Center for HIV/AIDS Vaccine Immunology (CHAVI)
Competing Interests
The authors have declared that no competing interests exist.
Author Contributions
Conceived and designed the experiments: PLM ESG LM. Performed the experiments: PLM NR BEL EC. Analyzed the data: PLM NR BEL ESG EC LM. Contributed reagents/materials/analysis tools: MRA GB KM SSAK CW. Wrote the paper: PLM ESG CW LM. Conceived, implemented and led the CAPRISA 002 Acute Infection study: KM SSAK CW.